Healt


 Sonic Healthcare (ASX:SHL) in Focus: Exploring Growth and Stability within ASX 200 Companies

Sonic Healthcare (ASX:SHL) in Focus: Exploring Growth and Stability within ASX 200 Companies

August 27, 2025 10:01 AM AEST| By Team Kalkine Media

Highlights,Sonic Healthcare positioned as a global leader in pathology and diagnostics,Stable revenue streams from essential healthcare services,Growing relevance of ethical and sustainable investments,SHL Shares in Perspective,Sonic Healthcare Ltd (...

 ASX 200 Companies Cochlear (ASX:COH) Driving Growth Through Innovation and Dividend Strength

ASX 200 Companies Cochlear (ASX:COH) Driving Growth Through Innovation and Dividend Strength

August 26, 2025 10:30 PM AEST| By Team Kalkine Media

Highlights,Cochlear demonstrates strong operational performance and consistent growth.,Dividend increase reflects the company’s focus on shareholder engagement.,Market trends indicate expanding demand for hearing solutions globally.,The,ASX 200 Compa...

 CleanSpace Holdings (ASX:CSX) Exhibits Strong Market Momentum Amid Mixed Business Performance

CleanSpace Holdings (ASX:CSX) Exhibits Strong Market Momentum Amid Mixed Business Performance

August 26, 2025 09:23 PM AEST| By Team Kalkine Media

Highlights,CleanSpace Holdings experiences notable share price movement.,Revenue growth shows short-term strength but longer-term moderation.,Price-to-sales ratio remains aligned with industry peers.,CleanSpace Holdings (ASX:CSX) has attracted market...

 Emyria Expands Empax PTSD Care Program with Perth Launch and National Growth Plans

Emyria Expands Empax PTSD Care Program with Perth Launch and National Growth Plans

August 26, 2025 12:40 PM AEST| By Team Kalkine Media

Highlights,Emyria expands PTSD care program in Perth.,Interstate rollout begins with Brisbane clinic.,Growing demand reflects rising mental health needs.,Emyria (ASX:EMD) has taken a significant step forward in its mission to transform mental health...

 EMVision Expands Pivotal Brain Scanner Trial with New US Site in Collaboration with UCLA Health

EMVision Expands Pivotal Brain Scanner Trial with New US Site in Collaboration with UCLA Health

August 26, 2025 11:39 AM AEST| By Team Kalkine Media

Highlights,EMVision activates new US site for pivotal emu brain scanner trial,UCLA Health joins multi-centre validation study,Federal grant supports regional stroke care research in Australia,EMVision Medical Devices (ASX:EMV) has advanced its pivota...

 Genetic Signatures (ASX:GSS) Strengthens Business Outlook Amid Market Growth

Genetic Signatures (ASX:GSS) Strengthens Business Outlook Amid Market Growth

August 26, 2025 09:56 AM AEST| By Team Kalkine Media

Highlights,Genetic Signatures shows progress in managing resources,Revenue growth supports long-term business potential,Analysts expect company to move toward stability,Genetic Signatures (ASX:GSS) continues to gain attention in the healthcare and di...

 CSL Share Price Outlook: Exploring CSL Ltd in the ASX 200

CSL Share Price Outlook: Exploring CSL Ltd in the ASX 200

August 25, 2025 04:54 PM AEST| By Team Kalkine Media

Highlights:,CSL Ltd (CSL) operates across three major business units.,Strong track record in biotechnology and healthcare solutions.,Financial performance reflects steady growth trends.,CSL Ltd (ASX:CSL) has long been one of the key companies listed...

 Ansell (ASX 200) Strengthens Growth with Buyback and Global Strategy

Ansell (ASX 200) Strengthens Growth with Buyback and Global Strategy

August 25, 2025 04:22 PM AEST| By Team Kalkine Media

Highlights,Ansell (ANN) announces new capital initiative.,Healthcare and industrial segments show steady progress.,Tariff and supply chain strategy supports resilience.,Ansell (ASX:ANN), a global leader in protective solutions, has outlined a major c...

 ASX 200 Telix Pharmaceuticals shares surge on half year performance update

ASX 200 Telix Pharmaceuticals shares surge on half year performance update

August 23, 2025 09:13 PM AEST| By Team Kalkine Media

Highlights,Telix Pharmaceuticals (ASX:TLX) recorded strong half year performance with revenue growth and margin stability,The company reaffirmed its full year guidance with upcoming product approvals and submissions in focus,Shares of Telix climbed w...

 Ramsay Health Care Faces Growth Challenges Within ASX 200 Landscape

Ramsay Health Care Faces Growth Challenges Within ASX 200 Landscape

August 23, 2025 08:50 PM AEST| By Team Kalkine Media

Highlights,Ramsay Health Care shows slower revenue expansion compared to industry peers,Market sentiment weighs on its valuation due to growth concerns,Future outlook raises questions about competitive positioning,Ramsay Health Care Limited (ASX:RHC)...

 Sonic Healthcare (ASX:SHL) and its Place in the ASX 200 Index: A Closer Look at 2025

Sonic Healthcare (ASX:SHL) and its Place in the ASX 200 Index: A Closer Look at 2025

August 23, 2025 08:40 PM AEST| By Team Kalkine Media

Highlights,Sonic Healthcare (SHL) remains a key player in global healthcare.,The company offers diverse medical and diagnostic services.,Valuation metrics highlight its performance and capital health.,Sonic Healthcare (ASX:SHL) is a leading player in...

 ASX 200 Healthcare Sector Faces Heavy Setback as CSL and Sonic Lead Declines

ASX 200 Healthcare Sector Faces Heavy Setback as CSL and Sonic Lead Declines

August 22, 2025 06:26 PM AEST| By Team Kalkine Media

Highlights,Healthcare companies on the Australian market index recorded sharp declines despite gains across the broader benchmark,CSL (ASX:CSL) faced its steepest fall after unveiling restructuring plans and a vaccine business separation,Sonic Health...

 Indexasx xjo Sonic Healthcare (ASX:SHL) movement after FY results update

Indexasx xjo Sonic Healthcare (ASX:SHL) movement after FY results update

August 22, 2025 04:09 PM AEST| By Team Kalkine Media

Highlights,Sonic Healthcare (ASX:SHL) shares recorded a notable decline following its FY results release,The healthcare group reported growth in revenue and operating profit but earnings after tax remained largely unchanged,Guidance pointed towards s...

 Artrya’s (ASX:AYA) Cash Strategy and Market Outlook Beyond the ASX 200

Artrya’s (ASX:AYA) Cash Strategy and Market Outlook Beyond the ASX 200

August 22, 2025 03:48 PM AEST| By Team Kalkine Media

Highlights,Artrya focuses on managing its cash position effectively,Company shows signs of controlling expenditure,Market outlook depends on future funding and operational progress,Artrya (ASX:AYA) has been gaining attention for its innovative work i...

 LTR Pharma Advances SPONTAN Shelf Life Extension Amid ASX 200 Healthcare Landscape

LTR Pharma Advances SPONTAN Shelf Life Extension Amid ASX 200 Healthcare Landscape

August 22, 2025 01:17 PM AEST| By Team Kalkine Media

Highlights,LTR Pharma (LTP) extends shelf life of SPONTAN spray,Stability supports global distribution readiness,Clinical data reinforces rapid onset performance,LTR Pharma (ASX:LTP) has achieved an important step forward with its erectile dysfunctio...

 Sonic Healthcare Faces Pressure After FY25 Results, Spotlight on ASX 200

Sonic Healthcare Faces Pressure After FY25 Results, Spotlight on ASX 200

August 22, 2025 12:48 PM AEST| By Team Kalkine Media

Highlights,Sonic Healthcare (SHL) reports full-year results.,Mixed performance across global divisions.,Market reacts cautiously to guidance.,Sonic Healthcare (ASX:SHL), a major player in global pathology services, released its FY25 financial results...

 Artrya Ltd Gains Strong Momentum on FDA Approval Amid ASX 200 Market Focus

Artrya Ltd Gains Strong Momentum on FDA Approval Amid ASX 200 Market Focus

August 21, 2025 08:16 PM AEST| By Team Kalkine Media

Highlights,Artrya Ltd (ASX:AYA) secures FDA approval for diagnostic platform,Expansion into U.S. healthcare market through strategic partnerships,Growing commercial opportunities with AI-powered heart disease detection,Artrya Ltd (ASX:AYA) has recent...

 Tryptamine Therapeutics Signs Landmark Deal to Advance Precision Psychiatry Research with Focus Beyond ASX 200

Tryptamine Therapeutics Signs Landmark Deal to Advance Precision Psychiatry Research with Focus Beyond ASX 200

August 21, 2025 04:47 PM AEST| By Team Kalkine Media

Highlights,Tryptamine Therapeutics enters agreement for precision psychiatry.,Collaboration with Imperial College London experts.,Development of EEG-based biomarker platform to advance mental health treatment.,Tryptamine Therapeutics (ASX:TRP) has ta...

 ASX 200 steadies as banks lift gains after CSL impact on healthcare sector

ASX 200 steadies as banks lift gains after CSL impact on healthcare sector

August 21, 2025 03:12 PM AEST| By Team Kalkine Media

Highlights,Banks and real estate stocks supported the market recovery within the ASX 200,Healthcare stocks eased after CSL (ASX:CSL) continued to weigh on sentiment,High-profile moves were seen across companies including HMC Capital (ASX:HMC), James...

 Artrya Gains FDA Clearance for Salix Coronary Plaque Module Amid ASX 200 Landscape

Artrya Gains FDA Clearance for Salix Coronary Plaque Module Amid ASX 200 Landscape

August 21, 2025 11:56 AM AEST| By Team Kalkine Media

Highlights,Artrya (AYA) secures FDA clearance for its Salix Coronary Plaque Module,Approval paves way for wider integration across US hospital systems,Technology offers faster detection and enhanced workflow efficiency,Artrya (ASX:AYA) has achieved a...

AU_advertise

Advertise your brand on Kalkine Media

Recent Articles






Investing Tips

Previous Next
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.